Agency
Planned Parenthood Association of Utah
Planned Parenthood Association of Utah was paid $1.38M by Medicaid between Jan 2018 and Dec 2024, across 28 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 23% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD ASSOCIATION OF UTAH
SALT LAKE CITY, UT 84102
SALT LAKE CITY, UT 84102
33aNPI1073549614assigned 06/24/2006
33bProvider typeVoluntary or Charitable Agency
28Total paid$1.38M
24GClaims40,080
24DCodes billed28
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 983 | $12K | |
| 2019 | 1,652 | $32K | |
| 2020 | 4,305 | $149K | |
| 2021 | 9,984 | $407K | |
| 2022 | 12,203 | $495K | |
| 2023 | 6,924 | $202K | |
| 2024incomplete | 4,029 | $81K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 23% | 7,359 | 6,959 | $319K |
| 81025 | 14% | 5,641 | 5,439 | $199K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 2,258 | 2,189 | $176K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 13% | 327 | 317 | $174K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10% | 2,869 | 2,801 | $138K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 8.9% | 3,317 | 3,261 | $123K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5.2% | 1,486 | 1,462 | $71K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.8% | 7,359 | 6,959 | $39K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.6% | 339 | 331 | $22K |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | 1.6% | 66 | 65 | $22K |
| 58300 | 1.3% | 352 | 349 | $17K | |
| 11981 | 1.2% | 178 | 175 | $17K |
16 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 677 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,228 | $10K |
| 11982 | <1% | 107 | $7K | |
| 86703 | <1% | 858 | $6K | |
| 58301 | <1% | 111 | $6K | |
| 99201 | <1% | 110 | $5K | |
| 83986 | <1% | 1,572 | $5K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 13 | $4K |
| J3490 | Unclassified drugs | <1% | 137 | $3K |
| 87210 | <1% | 1,857 | $2K | |
| 99000 | <1% | 461 | $313.29 | |
| 81002 | <1% | 145 | $263.26 | |
| 87390 | <1% | 55 | $170.51 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 132 | $110.08 |
| 86592 | <1% | 52 | $83.34 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 14 | $69.47 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGALLOWAY, KARRIE (CEO/PRESIDENT)